/SUSRF
SUSRF Stock - Surgical Science Sweden AB (publ)
Healthcare|Medical - Healthcare Information ServicesOTC
$3.63+0.00%
+$0.00 (+0.00%) • Dec 19
54
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.96
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $3.99
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SUSRF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$3.59 – $3.67
TARGET (TP)$4.17
STOP LOSS$3.34
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.60
52W High$16.33
52W Low$3.16
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $884.09M | $882.85M | $802.54M | $366.78M | $104.80M |
| Gross Profit | $597.90M | $612.88M | $531.52M | $265.94M | $88.36M |
| Gross Margin | 67.6% | 69.4% | 66.2% | 72.5% | 84.3% |
| Operating Income | $144.32M | $189.15M | $162.54M | $88.75M | $19.97M |
| Net Income | $131.65M | $233.97M | $187.97M | $86.25M | $15.61M |
| Net Margin | 14.9% | 26.5% | 23.4% | 23.5% | 14.9% |
| EPS | $2.58 | $4.59 | $3.70 | $2.03 | $0.45 |
Company Overview
Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based laparoscopic and endoscopic training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; and LapSim essence, a portable and ready-to-use VR simulator. The company also provides EndoSim system, an endoscopy simulator that delivers medical simulation training; TeamSim, a dynamic platform for inter-professional education development taking surgery simulation into the real world teamwork; Simball Box, which offers feedback on velocity with tutorial task videos showing a preferred approach; simbionix simulators; and robotic surgery simulators. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SUSRFBeat Rate
72%
Last 18 quarters
Avg Surprise
+566.1%
EPS vs Estimate
Beats / Misses
13/5
Last 12 quarters
Latest EPS
$0.04
Q4 2025
EPS Surprise History
Q1 24
+1518.9%
$1.92vs$0.12
Q2 24
+468.2%
$0.47vs$0.08
Q3 24
+731.2%
$0.56vs$0.07
Q4 24
+1072.3%
$0.84vs$0.07
Q1 25
+696.2%
$0.71vs$0.09
Q2 25
+1393.8%
$0.65vs$0.04
Q3 25
-152.8%
$-0.04vs$0.08
Q4 25
-43.3%
$0.04vs$0.08
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 12, 2026 | — | — | — | — |
Q1 2026 | Feb 19, 2026 | — | — | — | — |
Q4 2025 | Nov 13, 2025 | $0.08 | $0.04 | -43.3% | ✗ MISS |
Q3 2025 | Aug 21, 2025 | $0.08 | $-0.04 | -152.8% | ✗ MISS |
Q2 2025 | May 14, 2025 | $0.04 | $0.65 | +1393.8% | ✓ BEAT |
Q1 2025 | Feb 19, 2025 | $0.09 | $0.71 | +696.2% | ✓ BEAT |
Q4 2024 | Nov 14, 2024 | $0.07 | $0.84 | +1072.3% | ✓ BEAT |
Q3 2024 | Aug 22, 2024 | $0.07 | $0.56 | +731.2% | ✓ BEAT |
Q2 2024 | May 15, 2024 | $0.08 | $0.47 | +468.2% | ✓ BEAT |
Q1 2024 | Feb 21, 2024 | $0.12 | $1.92 | +1518.9% | ✓ BEAT |
Q3 2023 | Sep 30, 2023 | $0.06 | $0.93 | +1352.9% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | $0.07 | $0.76 | +985.3% | ✓ BEAT |
Q1 2023 | Mar 31, 2023 | $0.05 | $0.98 | +1851.4% | ✓ BEAT |
Q1 2023 | Feb 22, 2023 | $0.82 | $2.29 | +179.3% | ✓ BEAT |
Q4 2022 | Nov 10, 2022 | $0.63 | $0.56 | -11.1% | ✗ MISS |
Q3 2022 | Aug 25, 2022 | $0.50 | $0.52 | +4.0% | ✓ BEAT |
Q2 2022 | May 11, 2022 | $0.40 | $0.32 | -20.0% | ✗ MISS |
Q1 2022 | Feb 16, 2022 | $0.55 | $1.31 | +138.2% | ✓ BEAT |
Q4 2021 | Nov 10, 2021 | $0.20 | $0.33 | +65.0% | ✓ BEAT |
Q3 2021 | Aug 20, 2021 | $0.15 | $0.09 | -40.0% | ✗ MISS |
Latest News
Loading news...
Frequently Asked Questions about SUSRF
What is SUSRF's current stock price?
Surgical Science Sweden AB (publ) (SUSRF) is currently trading at $3.63 per share. The stock has moved +0.00% today.
What is the analyst price target for SUSRF?
No analyst price targets are currently available for this stock.
What sector is Surgical Science Sweden AB (publ) in?
Surgical Science Sweden AB (publ) operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the OTC exchange.
What is SUSRF's market cap?
Surgical Science Sweden AB (publ) has a market capitalization of $0.19 billion, making it a small-cap company.
Does SUSRF pay dividends?
No, Surgical Science Sweden AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAVCTF
Avacta Group Plc
$1.11
Mkt Cap: $0.5B
BOVNF
BioInvent International AB (publ)
$3.29
Mkt Cap: $0.2B
CLHLF
COLTENE Holding AG
$61.16
Mkt Cap: $0.4B
COGZF
Cogstate Limited
$1.43
Mkt Cap: $0.2B
HUMDF
Hua Medicine (Shanghai) Ltd.
$0.41
Mkt Cap: $0.4B
KHTRF
Knight Therapeutics Inc.
$4.41
Mkt Cap: $0.4B
KSIOF
Kneat.com, Inc.
$3.60
Mkt Cap: $0.3B
PTCHF
PureTech Health plc
$1.55
Mkt Cap: $0.4B
RAONF
Race Oncology Limited
$2.60
Mkt Cap: $0.5B
VHIBF
Vitalhub Corp.
$6.69
Mkt Cap: $0.4B
Explore stocks similar to SUSRF for comparison